RED HOT Contributors

 

J&J’s DePuy Synthes launches TFNA hip repair system

0
Share

DePuy Synthes

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it launched the TFNA augmentation system designed to treat patients with hip fractures who have poor bone quality.

The company touted the system as the 1st and only polymethylmethacrylate cement with indications for specific traumas. The system is designed to be used to enhance implant fixation in cases where there is a significant potential risk of cut-out.

“The TFNA Augmentation System addresses an important clinical need for patients who undergo hip fracture surgery, especially those who suffer from poor bone quality. This new system complements the TFNA System and has the potential to improve patient outcomes, reduce costs, and increase patient satisfaction,” DePuy Synthes trauma franchise medical leader Dr. Charisse Sparks said in a prepared statement.

Earlier this month, DePuy Synthes said it launched the Maxframe multi-axial limb correction system designed to gradually correct bone or soft tissue deformities in the arm, leg, foot or ankle.

DePuy said the Maxframe system includes 3D planning software intended to create accurate patient treatment plans and reduce the number of X-rays required and the procedural complexity of treatments.

About

We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast